ResMed (RMD) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $232.34 +1.04%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.55, $0.03 better than the analyst estimate of $2.52. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- V2X, INC (VVX) Tops Q2 EPS by 14c, Beats on Revenue; Offers FY26 Guidance
- Lattice Semiconductor (LSCC) Tops Q3 EPS by 17c, Beats on Revenue
- Syndax Pharmaceuticals (SNDX) Misses Q3 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
